Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 05, 2022

IN RE KIROMIC BIOPHARMA, INC. SECURITIES LITIGATION

Track this case

Case Number:

1:22-cv-06690

Court:

New York Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Jennifer H. Rearden

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 02, 2023

    Drug Co. Investors Settle Clinical Trial Suit For $2.3M

    Investors of biotherapeutics company Kiromic BioPharma Inc. asked a New York federal judge to initially approve a $2.3 million settlement in a suit accusing the company of touting prospects for two drug candidates ahead of a 2021 public offering despite knowing the U.S. Food and Drug Administration suspended the drugs' clinical trials.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login